Bard Associates’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$29.5K Buy
+300
New +$29.1K 0.01% 215

Other funds holding BNTX

Bard Associates's BNTX Position: Q3 2026 in Review

Bard Associates opened a new position in BioNTech (BNTX) in Q3 2026: 300 shares worth $29.5K. The stake represents 0.01% of the portfolio and ranks #215 among its holdings.

297 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

  • Bard Associates held 300 shares of BioNTech worth $29.5K as of Q3 2026.
  • BioNTech was a new Bard Associates position in Q3 2026.
  • BioNTech made up 0.01% of Bard Associates's portfolio in Q3 2026, its #215 holding.
  • 297 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on Bard Associates's 13F filing for Q3 2026, filed 13 Nov 2026.